Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Humira
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Humira 40mg/0.4ml solution for injection pre-filled pens
1001030S0BBADAD
|
Humira | Adalimumab | Musculoskeletal and Joint Diseases | 4 |
|
Humira 20mg/0.2ml solution for injection pre-filled syringes
1001030S0BBAFAF
|
Humira | Adalimumab | Musculoskeletal and Joint Diseases | 1 |
|
Humira 40mg/0.4ml solution for injection pre-filled syringes
1001030S0BBAEAE
|
Humira | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Humira 40mg/0.8ml solution for injection pre-filled pens
1001030S0BBABAB
|
Humira | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Humira 40mg/0.8ml solution for injection pre-filled syringes
1001030S0BBAAAA
|
Humira | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Humira 40mg/0.8ml solution for injection vials
1001030S0BBACAC
|
Humira | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Humira 80mg/0.8ml solution for injection pre-filled pens
1001030S0BBAHAH
|
Humira | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Humira 80mg/0.8ml solution for injection pre-filled syringes
1001030S0BBAGAG
|
Humira | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.